- Synonyms(2S,3S,4S,5R,6R)-6-(5-(4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-yl)-2H-tetrazol-2-yl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylicacid; 1-[5-[4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-?-D-glu...
- Description
(2S,3S,4S,5R,6R)-6-(5-(4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-yl)-2H-tetrazol-2-yl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylicacid; 1-[5-[4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-?-D-glucopyranuronic Acid
Irbesartan N2-Glucuronide is a fully characterized chemical compound used as a reference standard of API Irbesartan. The standard offered is compliant with regulatory guidelines. Irbesartan N2-Glucuronide is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 160205-58-3